Skip to main content

Table 2 Biochemical measurement participants stratified by low-density lipoprotein and high-sensitivity c-reactive protein concentrations

From: High-sensitivity C-reactive protein and low-density lipoprotein cholesterol association with incident of cardiovascular events: Isfahan cohort study

Metabolic risk factors

LDL-C < 130 mg/dL

LDL-C ≥ 130 mg/dL

hs-CRP < 3 mg/L

hs-CRP ≥ 3 mg/L

P value

hs-CRP < 3 mg/L

hs-CRP ≥ 3 mg/L

P value

Total cholesterol (mg/dL)

179.2 ± 32.2

176.8 ± 31.3

0.143

249.4 ± 38.6

253.8 ± 41.5

0.031

Triglyceride (mg/dL)

176.2 ± 99

176.9 ± 98

0.920

193.2 ± 104

198.4 ± 102.2

0.347

LDL-C (mg/dL)

97.6 ± 23.7

95.8 ± 23.5

0.164

163.4 ± 27.2

167.3 ± 30.7

0.007

HDL-C (mg/dL)

46.4 ± 10.6

45.7 ± 10.5

0.206

47.4 ± 9.5

46.8 ± 10.1

0.250

Apolipoprotein A (mg/dL)

150.7 ± 39.2

152.8 ± 39.4

0.752

149.9 ± 32.9

157.5 ± 34.3

0.148

Apolipoprotein B (mg/dL)

107.6 ± 23.9

113.6 ± 27.9

0.839

126.1 ± 32

126.5 ± 35

0.915

FBG (mg/dL)

87.4 ± 31.6

86.3 ± 28

0.451

91.3 ± 34.7

95.4 ± 40.6

0.033

  1. LDL-C: low density lipoprotein cholesterol; Hs-CRP: hs-C-reactive protein; HDL-C: high density lipoprotein cholesterol; FBG: fasting blood glucose
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us